Theratechnologies Shares Outstanding vs. Revenue
| TH Stock | CAD 1.70 0.02 1.19% |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.96 | 0.87 |
|
|
For Theratechnologies profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Theratechnologies to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Theratechnologies utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Theratechnologies's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Theratechnologies over time as well as its relative position and ranking within its peers.
Theratechnologies |
Theratechnologies Revenue vs. Shares Outstanding Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Theratechnologies's current stock value. Our valuation model uses many indicators to compare Theratechnologies value to that of its competitors to determine the firm's financial worth. Theratechnologies is currently regarded as top stock in shares outstanding category among its peers. It also is currently regarded number one company in revenue category among its peers totaling about 1.78 of Revenue per Shares Outstanding. At this time, Theratechnologies' Total Revenue is very stable compared to the past year. Comparative valuation analysis is a catch-all model that can be used if you cannot value Theratechnologies by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Theratechnologies' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Theratechnologies Revenue vs. Shares Outstanding
Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Theratechnologies |
| = | 45.98 M |
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Theratechnologies |
| = | 81.76 M |
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Theratechnologies Revenue vs Competition
Theratechnologies is currently regarded number one company in revenue category among its peers. Market size based on revenue of Health Care industry is at this time estimated at about 176.7 Billion. Theratechnologies adds roughly 81.76 Million in revenue claiming only tiny portion of equities under Health Care industry.
Theratechnologies Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Theratechnologies, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Theratechnologies will eventually generate negative long term returns. The profitability progress is the general direction of Theratechnologies' change in net profit over the period of time. It can combine multiple indicators of Theratechnologies, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 786.6 K | 825.9 K | |
| Operating Income | -9.6 M | -10 M | |
| Income Before Tax | -21.2 M | -20.1 M | |
| Total Other Income Expense Net | -11.6 M | -11 M | |
| Net Loss | -21.6 M | -20.5 M | |
| Income Tax Expense | 484.1 K | 508.4 K | |
| Net Loss | -21.6 M | -22.6 M | |
| Net Loss | -42.5 M | -40.4 M | |
| Interest Income | 884.4 K | 840.1 K | |
| Net Interest Income | -9.5 M | -9.1 M | |
| Change To Netincome | 8.1 M | 8.5 M | |
| Net Loss | (1.05) | (0.99) | |
| Income Quality | 0.21 | 0.20 | |
| Net Income Per E B T | 1.17 | 1.09 |
Theratechnologies Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Theratechnologies. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Theratechnologies position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Theratechnologies' important profitability drivers and their relationship over time.
Use Theratechnologies in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Theratechnologies position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Theratechnologies will appreciate offsetting losses from the drop in the long position's value.Theratechnologies Pair Trading
Theratechnologies Pair Trading Analysis
The ability to find closely correlated positions to Theratechnologies could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Theratechnologies when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Theratechnologies - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Theratechnologies to buy it.
The correlation of Theratechnologies is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Theratechnologies moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Theratechnologies moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Theratechnologies can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Theratechnologies position
In addition to having Theratechnologies in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Beer and Liquor Thematic Idea Now
Beer and Liquor
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Beer and Liquor theme has 32 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Beer and Liquor Theme or any other thematic opportunities.
| View All Next | Launch |
Check out World Market Map. To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.You can also try the Earnings Calls module to check upcoming earnings announcements updated hourly across public exchanges.
To fully project Theratechnologies' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Theratechnologies at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Theratechnologies' income statement, its balance sheet, and the statement of cash flows.